Sosei Heptares Webinar Presentation for Q2 FY2022 Financial Results

TOKYO, Japan and CAMBRIDGE, United Kingdom, July 11, 2022 (GLOBE NEWSWIRE) -- Sosei Group Corporation ("the Company"; TSE: 4565) will announce its earnings results and present operational highlights for the 6 months ended 30 June 2022 on Wednesday, 10 August 2022. The Company will host a webinar presentation with Chris Cargill, President and CEO, Matt Barnes, President of Heptares Therapeutics and Head of UK R&D, and Hironoshin Nomura, ... Full story available on Benzinga.com